期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 106, 期 19, 页码 8043-8048出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.0900358106
关键词
astrocytes; Parkinson's disease; extraneuronal monoamine transporter; dopamine; methamphetamine
资金
- National Institutes of Health [ES014899, P30 ES01247, T32 ES07026, NS0641912, NS062180, NS042269, NS3837009, AG021617]
- National Institute of Environmental Health Sciences [ES014899-02S1]
- U. S. Department of Defense [W81WXWH-08-1-0465, W81WXWH-08-1-0522]
- Parkinson's Disease Foundation
- Thomas Hartman Foundation for Parkinson's Research
Toxic organic cations can damage nigrostriatal dopaminergic pathways as seen in most parkinsonian syndromes and in some cases of illicit drug exposure. Here, we show that the organic cation transporter 3 (Oct3) is expressed in nondopaminergic cells adjacent to both the soma and terminals of midbrain dopaminergic neurons. We hypothesized that Oct3 contributes to the dopaminergic damage by bidirectionally regulating the local bioavailability of toxic species. Consistent with this view, Oct3 deletion and pharmacological inhibition hampers the release of the toxic organic cation 1-methyl-4-phenylpyridinium from astrocytes and protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration in mice. Furthermore, Oct3 deletion impairs the removal of the excess extracellular dopamine induced by methamphetamine and enhances striatal dopaminergic terminal damage caused by this psychostimulant. These results may have far-reaching implications for our understanding of the mechanism of cell death in a wide range of neurodegenerative diseases and may open new avenues for neuroprotective intervention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据